Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View expanded data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View expanded data table
# of AnimalsPhenotypeStrainSexValueUnitsConditionsRecord IDCondition 1Condition 2aCondition 2bCondition 3
12blood vessel contractile force measurementSS/Jrmale1.39gKreb's solution perfusate then potassium chloride solution (40 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) 69050Kreb's solution perfusatepotassium chloride solution (40 mmol/l) NG-nitroarginine methyl ester (100 umol/l)
12blood vessel contractile force measurementSS/Jrmale1.59gKreb's solution perfusate then potassium chloride solution (40 mmol/l) 69048Kreb's solution perfusatepotassium chloride solution (40 mmol/l)
12logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50)SS/Jrmale-7.6Kreb's solution perfusate then phenylephrine (1~100 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) 69058Kreb's solution perfusatephenylephrine (1~100 mmol/l) NG-nitroarginine methyl ester (100 umol/l)
12logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50)SS/Jrmale-7.26Kreb's solution perfusate then phenylephrine (1~100 mmol/l) 69054Kreb's solution perfusatephenylephrine (1~100 mmol/l)
12receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratioSS/Jrmale141.72%Kreb's solution perfusate then phenylephrine (1~100 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) 69056Kreb's solution perfusatephenylephrine (1~100 mmol/l) NG-nitroarginine methyl ester (100 umol/l)
12receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratioSS/Jrmale104.06%Kreb's solution perfusate then phenylephrine (1~100 mmol/l) 69052Kreb's solution perfusatephenylephrine (1~100 mmol/l)
12receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratioSS/Jrmale50.61%Kreb's solution perfusate then angiotensin II (0.3~300 umol/l) and NG-nitroarginine methyl ester (100 umol/l) 69069Kreb's solution perfusateangiotensin II (0.3~300 umol/l) NG-nitroarginine methyl ester (100 umol/l)
12receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratioSS/Jrmale34.85%Kreb's solution perfusate then angiotensin II (0.3~300 umol/l) 69065Kreb's solution perfusateangiotensin II (0.3~300 umol/l)
12logarithm of the concentration of angiotensin II at which the force of blood vessel contraction is half the maximum value (Log EC50)SS/Jrmale-7.92Kreb's solution perfusate then angiotensin II (0.3~300 umol/l) then NG-nitroarginine methyl ester (100 umol/l) 69071Kreb's solution perfusateangiotensin II (0.3~300 umol/l) NG-nitroarginine methyl ester (100 umol/l)
12logarithm of the concentration of angiotensin II at which the force of blood vessel contraction is half the maximum value (Log EC50)SS/Jrmale-8.22Kreb's solution perfusate then angiotensin II (0.3~300 umol/l) 69067Kreb's solution perfusateangiotensin II (0.3~300 umol/l)